Nature Communications (Oct 2018)

APOE ε2 is associated with increased tau pathology in primary tauopathy

  • Na Zhao,
  • Chia-Chen Liu,
  • Alexandra J. Van Ingelgom,
  • Cynthia Linares,
  • Aishe Kurti,
  • Joshua A. Knight,
  • Michael G. Heckman,
  • Nancy N. Diehl,
  • Mitsuru Shinohara,
  • Yuka A. Martens,
  • Olivia N. Attrebi,
  • Leonard Petrucelli,
  • John D. Fryer,
  • Zbigniew K. Wszolek,
  • Neill R. Graff-Radford,
  • Richard J. Caselli,
  • Monica Y. Sanchez-Contreras,
  • Rosa Rademakers,
  • Melissa E. Murray,
  • Shunsuke Koga,
  • Dennis W. Dickson,
  • Owen A. Ross,
  • Guojun Bu

DOI
https://doi.org/10.1038/s41467-018-06783-0
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 11

Abstract

Read online

The APOE ε4 allele is a strong genetic risk factor for Alzheimer’s disease, whereas the APOE ε2 allele is protective. Here the authors show that mice expressing the human APOE ε2/ε2 genotype have increased tau pathology and related behavioral deficits; they also find that the APOE ε2 allele is associated with an increased burden of tau pathology in postmortem human brains with progressive supranuclear palsy.